TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities

Methods in Enzymology

Volumn 485, Issue C, 2010, Pages 393-420

  Sanders, Jane ^a   Núñez Miguel, Ricardo ^a   Furmaniak, Jadwiga ^a   Rees Smith, Bernard ^a  

^a RSR LTD   (United Kingdom)

Author keywords

Cyclic AMP; Graves' disease; TSH; TSH receptor; TSH receptor antibodies

Indexed keywords

CYCLIC AMP; LEUCINE RICH REPEAT KINASE 2; MONOCLONAL ANTIBODY 5C9; MONOCLONAL ANTIBODY B2; MONOCLONAL ANTIBODY K1 70; MONOCLONAL ANTIBODY M22; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY STRUCTURE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; B LYMPHOCYTE; BIOLOGICAL ACTIVITY; BODY SURFACE POTENTIAL; BOOK; CELL IMMORTALIZATION; CELL ISOLATION; CHO CELL; DNA IMMUNIZATION; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ANALYSIS; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; LIGAND BINDING; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHARMACODYNAMICS; PRIORITY JOURNAL; THYROID DISEASE; X RAY CRYSTALLOGRAPHY;

ANIMALIA; CRICETINAE;

EID: 78049488270     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381296-4.00022-1     Document Type: Chapter

References (62)

1. Akamizu T., Matsuda F., Okuda J., Li H., Kanda H., Watanabe T., Honjo T., Mori T. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs. J. Immunol. 1996, 157:3148-3152.
2. Akamizu T., Moriyama K., Miura M., Saijo M., Matsuda F., Nakao K. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: Epitope and binding study of two stimulatory TSHRAbs. Endocrinology 1999, 140:1594-1601.
3. Ando T., Latif R., Pritsker A., Moran T., Nagayama Y., Davies T.F. A monoclonal thyroid-stimulating antibody. J. Clin. Invest. 2002, 110:1667-1674.
4. Bolton J., Sanders J., Oda Y., Chapman C., Konno R., Furmaniak J., Rees Smith B. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clin. Chem. 1999, 45:2285-2287.
5. Chen C.R., McLachlan S.M., Rapoport B. Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology 2007, 148:2375-2382.
6. Chen C.R., McLachlan S.M., Rapoport B. Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties. Endocrinology 2008, 149:3427-3434.
7. Costagliola S., Rodien P., Many M.C., Ludgate M., Vassart G. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J. Immunol. 1998, 160:1458-1465.
8. Costagliola S., Panneels V., Bonomi M., Koch J., Many M.C., Smits G., Vassart G. Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J. 2002, 21:504-513.
9. Costagliola S., Franssen J.D., Bonomi M., Urizar E., Willnich M., Bergmann A., Vassart G. Generation of a mouse monoclonal TSH receptor antibody with stimulating activity. Biochem. Biophys. Res. Commun. 2002, 299:891-896.
10. Costagliola S., Bonomi M., Morgenthaler N.G., Van Durme J., Panneels V., Refetoff S., Vassart G. Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol. Endocrinol. 2004, 18:3020-3034.
11. Davies T.F., Bobovnikova Y., Weiss M., Vlase H., Moran T., Graves P.N. Development and characterization of monoclonal antibodies specific for the murine thyrotropin receptor. Thyroid 1998, 8:693-701.
12. De Lano W.L. The Pymol Molecular Graphics System 2002, DeLano Scientific, San Carlos, CA. http://pymol.sourceforge.net/.
13. de StGroth S.F., Scheidegger D. Production of monoclonal antibodies: Strategy and tactics. J. Immunol. Methods 1980, 35:1-21.
14. Evans M., Sanders J., Tagami T., Sanders P., Young S., Roberts E., Wilmot J., Hu X., Kabelis K., Clark J., Holl S., Richards T., et al. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin. Endocrinol. 2010, 73:404-412.
15. Fan Q.R., Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 2005, 433:269-277.
16. Gilbert J.A., Gianoukakis A.G., Salehi S., Moorhead J., Rao P.V., Khan M.Z., McGregor A.M., Smith T.J., Banga J.P. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways. J. Immunol. 2006, 176:5084-5092.
17. Hasan U.A., Abai A.M., Harper D.R., Wren B.W., Morrow W.J. Nucleic acid immunization: Concepts and techniques associated with third generation vaccines. J. Immunol. Methods 1999, 229:1-22.
18. Hayakawa N., Premawardhana L.D.K.E., Powell M., Masuda M., Arnold C., Sanders J., Evans M., Chen S., Jaume J.C., Baekkeskov S., Rees Smith B., Furmaniak J. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase. Autoimmunity 2002, 35:343-355.
19. Horimoto M., Petersen V.B., Pegg C.A.S., Fukuma N., Wabayashi N., Kiso Y., Furmaniak J., Rees Smith B. Production and characterization of a human monoclonal thyroid peroxidase autoantibody. Autoimmunity 1992, 14:1-7.
20. Jeffreys J., Depraetere H., Sanders J., Oda Y., Evans M., Kiddie A., Richards T., Furmaniak J., Rees Smith B. Characterization of the thyrotropin binding pocket. Thyroid 2002, 12:1051-1061.
21. Kleinau G., Krause G. Thyrotropin and homologous glycoprotein hormone receptors: Structural and functional aspects of extracellular signaling mechanisms. Endocr. Rev. 2009, 30:133-151.
22. Kohn L.D., Suzuki K., Hoffman W.H., Tombaccini D., Marcocci C., Shimojo N., Watanabe Y., Amino N., Cho B.Y., Kohno Y., Hirai A., Tahara K. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J. Clin. Endocrinol. Metab. 1997, 82:3998-4009.
23. Kopp P., Muirhead S., Jourdain N., Gu W.-X., Jameson J.L., Rodd C. Congenital hyperthyroidism caused by solitary toxic adenoma harboring a novel somatic mutation (serine281 to isoleucine) in the extracellular domain of the thyrotropin receptor. J. Clin. Invest. 1997, 100:1634-1639.
24. Kosugi S., Ban T., Akamizu T., Kohn L.D. Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains. J. Biol. Chem. 1991, 266:19413-19418.
25. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK-A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26:283-291.
26. Lenzner C., Morgenthaler N.G. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease. Thyroid 2003, 13:1153-1161.
27. Luthy R., Bowie J.U., Eisenberg D. Assessment of protein models with 3-dimensional profiles. Nature 1992, 356:83-85.
28. McKenzie J.M., Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992, 2:155-159.
29. McLachlan S.M., Rapoport B. Monoclonal, human autoantibodies to the TSH receptor-The Holy Grail and why are we looking for it?. J. Clin. Endocrinol. Metab. 1996, 81:3152-3154.
30. Minich W.B., Lenzner C., Morgenthaler N.G. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin. Exp. Immunol. 2004, 136:129-136.
31. Morgenthaler N.G., Kim M.R., Tremble J., Huang G.C., Richter W., Gupta M., Scherbaum W.A., McGregor A.M., Banga J.P. Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: Characterization by immunoprecipitation with recombinant antigen and biological activity. J. Clin. Endocrinol. Metab. 1996, 81:3155-3161.
32. Moriyama K., Okuda J., Saijo M., Hattori Y., Kanamoto N., Hataya Y., Matsuda F., Mori T., Nakao K., Akamizu T. Recombinant monoclonal thyrotropin-stimulation blocking antibody (TSBAb) established from peripheral lymphocytes of a hypothyroid patient with primary myxedema. J. Endocrinol. Invest. 2003, 26:1076-1080.
33. Mueller S., Kleinau G., Jaeschke H., Paschke R., Krause G. Extended hormone binding site of the human thyroid stimulating hormone receptor: Distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation. J. Biol. Chem. 2008, 283:18048-18055.
34. Mueller S., Kleinau G., Szkudlinski M.W., Jaeschke H., Krause G., Paschke R. The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor. J. Biol. Chem. 2009, 284:16317-16324.
35. Núñez Miguel R., Sanders J., Jeffreys J., Depraetere H., Evans M., Richards T., Blundell T.L., Rees Smith B., Furmaniak J. Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. Thyroid 2004, 14:991-1011.
36. Núñez Miguel R., Sanders J., Blundell T.L., Rees Smith B., Furmaniak J. Comparative modeling of the thyrotropin receptor. Thyroid 2005, 15:746-747.
37. Núñez Miguel R., Sanders J., Chirgadze D.Y., Blundell T.L., Furmaniak J., Rees Smith B. FSH and TSH binding to their respective receptors: Similarities, differences and implication for glycoprotein hormone specificity. J. Mol. Endocrinol. 2008, 41:145-164.
38. Núñez Miguel R., Sanders J., Chirgadze D.Y., Furmaniak J., Rees Smith B. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: A comparative structural study of protein-protein interactions. J. Mol. Endocrinol. 2009, 42:381-395.
39. Oda Y., Sanders J., Roberts S., Maruyama M., Kato R., Perez M., Petersen V.B., Wedlock N., Furmaniak J., Rees Smith B. Binding characteristics of antibodies to the TSH receptor. J. Mol. Endocrinol. 1998, 20:233-244.
40. Oda Y., Sanders J., Evans M., Kiddie A., Munkley A., James C., Richards T., Wills J., Furmaniak J., Rees Smith B. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid 2000, 10:1051-1059.
41. Okuda J., Akamizu T., Sugawa H., Matsuda F., Hua L., Mori T. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema. J. Clin. Endocrinol. Metab. 1994, 79:1600-1604.
42. Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993, 365:649-651.
43. 2+ cascades. Mol. Endocrinol. 1995, 9:725-733.
44. Rapoport B., Chazenbalk G.D., Jaume J.C., McLachlan S.M. The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr. Rev. 1998, 19:673-716.
45. Rees Smith B., McLachlan S.M., Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr. Rev. 1988, 9:106-121.
46. Rees Smith B., Sanders J., Furmaniak J. TSH receptor antibodies. Thyroid 2007, 17:923-938.
47. Rees Smith B., Sanders J., Evans M., Tagami T., Furmaniak J. TSH receptor-autoantibody interactions. Horm. Metab. Res. 2009, 41:448-455.
48. Sali A., Blundell T.L. Definition of general topological equivalence in protein structures. J. Mol. Biol. 1989, 212:403-428.
49. Sanders J., Oda Y., Roberts S.A., Maruyama M., Furmaniak J., Rees Smith B. Understanding the thyrotropin receptor function-structure relationship. Baillières Clin. Endocrinol. Metab. 1997, 11:451-479.
50. 125 I-labelled TSH receptor. J. Clin. Endocrinol. Metab. 1999, 84:797-802.
51. Sanders J., Jeffreys J., Depraetere H., Richards T., Evans M., Kiddie A., Brereton K., Groenen M., Oda Y., Furmaniak J., Rees Smith B. Thyroid-stimulating monoclonal antibodies. Thyroid 2002, 12:1043-1050.
52. Sanders J., Evans M., Premawardhana L.D.K.E., Depraetere H., Jeffreys J., Richards T., Furmaniak J., Rees Smith B. Human monoclonal thyroid stimulating autoantibody. Lancet 2003, 362:126-128.
53. Sanders J., Jeffreys J., Depraetere H., Evans M., Richards T., Kiddie A., Brereton K., Premawardhana L.D., Chirgadze D.Y., Núñez Miguel R., Blundell T.L., Furmaniak J., et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: Sequence structure and function. Thyroid 2004, 14:560-570.
54. Sanders J., Allen F., Jeffreys J., Bolton J., Richards T., Depraetere H., Nakatake N., Evans M., Kiddie A., Premawardhana L.D.K.E., Chirgadze D.Y., Miguel R.N., et al. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid 2005, 15:672-682.
55. Sanders J., Bolton J., Sanders P., Jeffreys J., Nakatake N., Richards T., Evans M., Kiddie A., Summerhayes S., Roberts E., Miguel R.N., Furmaniak J., et al. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid 2006, 16:1195-1206.
56. Sanders J., Chirgadze D.Y., Sanders P., Baker S., Sullivan A., Bhardwaja A., Bolton J., Reeve M., Nakatake N., Evans M., Richards T., Powell M., et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 2007, 17:395-410.
57. Sanders J., Núñez Miguel R., Bolton J., Bhardwaja A., Sanders P., Nakatake N., Evans M., Furmaniak J., Rees Smith B. Molecular interactions between the TSH receptor and a thyroid-stimulating monoclonal autoantibody. Thyroid 2007, 17:699-706.
58. Sanders J., Evans M., Betterle C., Sanders P., Bhardwaja A., Young S., Roberts E., Wilmot J., Richards T., Kiddie A., Small K., Platt H., et al. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid 2008, 18:735-746.
59. Shepherd P.S., Da Costa C.R., Cridland J.C., Gilmore K.S., Johnstone A.P. Identification of an important thyrotrophin binding site on the human thyrotrophin receptor using monoclonal antibodies. Mol. Cell. Endocrinol. 1999, 149:197-206.
60. Valente W.A., Vitti P., Yavin Z., Yavin E., Rotella C.M., Grollman E.F., Toccafondi R.S., Kohn L.D. Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lymphocytes of patients with Graves' disease. Proc. Natl. Acad. Sci. USA 1982, 79:6680-6684.
61. Vlase H., Weiss M., Graves P.N., Davies T.F. Characterization of the murine immune response to the murine TSH receptor ectodomain: Induction of hypothyroidism and TSH receptor antibodies. Clin. Exp. Immunol. 1998, 113:111-118.
62. Yoshida T., Ichikawa Y., Ito K., Homma M. Monoclonal antibodies to the thyrotropin receptor bind to a 56-kDa subunit of the thyrotropin receptor and show heterogeneous bioactivities. J. Biol. Chem. 1988, 263:16341-16347.